Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
5
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
startups
clinical trials
new york top stories
blackstone group
david goldstein
depression
epilepsy
essential tremor
kiran reddy
major depressive disorder
perimenopausal depression
praxis precision medicines
san francisco blog main
san francisco top stories
steven petrou
third rock ventures
venture capital
20/20 healthcare partners
adeno-associated virus
aligos therapeutics
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
antisense oligonucleotide
azacitidine
baker brothers life sciences
benzodiazepine
benzodiazepines
beta-thalassemia
biogen
biotech ipos
blackstone life sciences
What
drugs
5
×
medicines
new
research
aims
emerged
neuro
praxis
precision
therapeutics
adding
ago
aiming
approach
associated
backed
balance
based
biotech
biotechs
build
called
cause
central
ceo
cns
companies
debuts
decibel
develop
developing
device
dialysis
disease
diseases
disorder
enclear
epigenetic
epigenetics
epilepsy
Language
unset
5
×
Current search:
boston
×
unset
×
drugs
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further